ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

NIH Open “One-Stop Shop” For Mutant Mouse Models.

July 20, 2001

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001